Dr. Chakraborty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
205 S Orange Ave
Newark, NJ 07103Phone+1 973-972-6257Fax+1 973-972-8390
Education & Training
- University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 2005 - 2008
- Maulana Azad Medical CollegeResidency (Clinical Pathology), Clinical Pathology, 2001 - 2004
- Maulana Azad Medical CollegeClass of 2000
Certifications & Licensure
- NY State Medical License 2008 - 2026
- NJ State Medical License 2008 - 2025
- VA State Medical License 2009 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Publications & Presentations
PubMed
- 16 citationsPembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170.Pier Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski
Blood. 2023-07-13 - 168 citationsAdenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trialsPatrick M. Dillon, Samhita Chakraborty, Christopher A. Moskaluk, Prashant J. Joshi, Christopher Y. Thomas
Head & Neck. 2016-04-01 - 23 citationsFive-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.Philippe Armand, Pier Luigi Zinzani, Hun Ju Lee, Nathalie A Johnson, Pauline Brice
Blood. 2023-09-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: